英国癌症研究会启动肺癌发病及癌细胞变异机制研究

2013-07-23 koo bio360

人们往往会将肺癌与吸烟习惯联系起来。然而日前,英国癌症专家提醒说,该国由吸烟之外的其他因素诱发的肺癌患者比例不断上升,这一现象值得警惕。 英国癌症研究会当天发表公报说,近年来许多禁烟措施的效果逐渐显现,英国吸烟者人数持续下降,然而肺癌仍是该国第一大癌症杀手,其中一个重要原因就是肺癌其他诱发因素的增多。尽管目前吸烟仍是英国肺癌的首要诱发因素,但由粉尘吸入等其他因素引发的肺癌患者比例不断上升,已从十

人们往往会将肺癌与吸烟习惯联系起来。然而日前,英国癌症专家提醒说,该国由吸烟之外的其他因素诱发的肺癌患者比例不断上升,这一现象值得警惕。

英国癌症研究会当天发表公报说,近年来许多禁烟措施的效果逐渐显现,英国吸烟者人数持续下降,然而肺癌仍是该国第一大癌症杀手,其中一个重要原因就是肺癌其他诱发因素的增多。尽管目前吸烟仍是英国肺癌的首要诱发因素,但由粉尘吸入等其他因素引发的肺癌患者比例不断上升,已从十分之一上升至五分之一。

英国癌症研究会执行主任哈帕尔·库马尔说,长期以来,人们认为吸烟者是肺癌的主要受害人群,这种观念应该有所改变,目前两成肺癌患者与吸烟毫无关系。他表示,肺癌诱发因素和肺癌诊断等方面的研究亟待加强。

英国癌症研究会当天还启动一项肺癌研究,旨在探索肺癌发病以及癌细胞变异的详细机制。这项研究投资 1400 万英镑(约合 2123 万美元),将招募 850 名患者参与,计划历时 9 年完成。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1799778, encodeId=30c71e99778ce, content=<a href='/topic/show?id=9e3fe127909' target=_blank style='color:#2F92EE;'>#癌发病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71279, encryptionId=9e3fe127909, topicName=癌发病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Fri Oct 25 02:59:00 CST 2013, time=2013-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056115, encodeId=c12f2056115e7, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Nov 08 15:59:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811219, encodeId=9705181121996, content=<a href='/topic/show?id=f9da8e10931' target=_blank style='color:#2F92EE;'>#英国癌症研究会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87109, encryptionId=f9da8e10931, topicName=英国癌症研究会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Oct 27 04:59:00 CST 2013, time=2013-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251941, encodeId=8537125194105, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342279, encodeId=97e013422e9e2, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514118, encodeId=a10b1514118a0, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1799778, encodeId=30c71e99778ce, content=<a href='/topic/show?id=9e3fe127909' target=_blank style='color:#2F92EE;'>#癌发病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71279, encryptionId=9e3fe127909, topicName=癌发病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Fri Oct 25 02:59:00 CST 2013, time=2013-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056115, encodeId=c12f2056115e7, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Nov 08 15:59:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811219, encodeId=9705181121996, content=<a href='/topic/show?id=f9da8e10931' target=_blank style='color:#2F92EE;'>#英国癌症研究会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87109, encryptionId=f9da8e10931, topicName=英国癌症研究会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Oct 27 04:59:00 CST 2013, time=2013-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251941, encodeId=8537125194105, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342279, encodeId=97e013422e9e2, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514118, encodeId=a10b1514118a0, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1799778, encodeId=30c71e99778ce, content=<a href='/topic/show?id=9e3fe127909' target=_blank style='color:#2F92EE;'>#癌发病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71279, encryptionId=9e3fe127909, topicName=癌发病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Fri Oct 25 02:59:00 CST 2013, time=2013-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056115, encodeId=c12f2056115e7, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Nov 08 15:59:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811219, encodeId=9705181121996, content=<a href='/topic/show?id=f9da8e10931' target=_blank style='color:#2F92EE;'>#英国癌症研究会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87109, encryptionId=f9da8e10931, topicName=英国癌症研究会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Oct 27 04:59:00 CST 2013, time=2013-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251941, encodeId=8537125194105, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342279, encodeId=97e013422e9e2, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514118, encodeId=a10b1514118a0, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1799778, encodeId=30c71e99778ce, content=<a href='/topic/show?id=9e3fe127909' target=_blank style='color:#2F92EE;'>#癌发病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71279, encryptionId=9e3fe127909, topicName=癌发病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Fri Oct 25 02:59:00 CST 2013, time=2013-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056115, encodeId=c12f2056115e7, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Nov 08 15:59:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811219, encodeId=9705181121996, content=<a href='/topic/show?id=f9da8e10931' target=_blank style='color:#2F92EE;'>#英国癌症研究会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87109, encryptionId=f9da8e10931, topicName=英国癌症研究会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Oct 27 04:59:00 CST 2013, time=2013-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251941, encodeId=8537125194105, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342279, encodeId=97e013422e9e2, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514118, encodeId=a10b1514118a0, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
    2013-07-25 yxch36
  5. [GetPortalCommentsPageByObjectIdResponse(id=1799778, encodeId=30c71e99778ce, content=<a href='/topic/show?id=9e3fe127909' target=_blank style='color:#2F92EE;'>#癌发病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71279, encryptionId=9e3fe127909, topicName=癌发病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Fri Oct 25 02:59:00 CST 2013, time=2013-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056115, encodeId=c12f2056115e7, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Nov 08 15:59:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811219, encodeId=9705181121996, content=<a href='/topic/show?id=f9da8e10931' target=_blank style='color:#2F92EE;'>#英国癌症研究会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87109, encryptionId=f9da8e10931, topicName=英国癌症研究会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Oct 27 04:59:00 CST 2013, time=2013-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251941, encodeId=8537125194105, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342279, encodeId=97e013422e9e2, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514118, encodeId=a10b1514118a0, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1799778, encodeId=30c71e99778ce, content=<a href='/topic/show?id=9e3fe127909' target=_blank style='color:#2F92EE;'>#癌发病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71279, encryptionId=9e3fe127909, topicName=癌发病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Fri Oct 25 02:59:00 CST 2013, time=2013-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056115, encodeId=c12f2056115e7, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Nov 08 15:59:00 CST 2013, time=2013-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811219, encodeId=9705181121996, content=<a href='/topic/show?id=f9da8e10931' target=_blank style='color:#2F92EE;'>#英国癌症研究会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87109, encryptionId=f9da8e10931, topicName=英国癌症研究会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Oct 27 04:59:00 CST 2013, time=2013-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251941, encodeId=8537125194105, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342279, encodeId=97e013422e9e2, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514118, encodeId=a10b1514118a0, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Thu Jul 25 04:59:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]

相关资讯

肺移植治疗肺癌的经验分享

        肺部恶性肿瘤的治疗手段主要包括手术治疗、化疗、放疗、靶向治疗、免疫治疗及中医治疗等。但是,当伴有肺功能下降、呼吸衰竭(如伴有终末期肺疾病)时,常规治疗方式反而可能会引起肺功能进行性恶化、加剧呼吸衰竭,最终导致死亡

CCC:吸烟者饮食中砷摄入量过多更易导致肺癌

日本国立癌症研究中心5日发表的一项研究结果显示,长期食用海藻等含砷海鲜类食物吸烟男性,患肺癌的几率比不食用此类食物的吸烟男性高。而对不吸烟的男性来说,砷摄入量越多,患肺癌的几率反而越低。对此,该研究中心呼吁“要想防肺癌就先戒烟”。   该研究中心将目光集中在日常饮食中砷元素摄入量和患癌症的关系。通过针对9个府县90378名45-74岁的男女性之间长达1

J Thorac Dis:吴一龙等研究认为应对疑似肺癌患者活检原则进行权衡考量

PET/CT扫描结果 占位部针刺活检及肌内结节切除样本 支气管镜及右上肺叶切除样本 在2013年6月期的《胸科疾病杂志》(Journalof Thoracic Disease)上,发表了我国广东省人民医院吴一龙教授等人的一篇文章。该文对活检原则进行了重新审视。在临床实践中,可通过多种手段获取到疑似肺癌患者的活检样本。既往文献认为,为达到诊断目的

1例肺炎误诊为肺癌

    患者女性,51岁,自诉体健,体型稍胖,吸烟约30余年,每天20余支。否认高血压病、冠心病、糖尿病病史,否认肝炎及结核等传染病史,否认重大外伤史及手术史。患者缘于3月余前无明显诱因出现咳嗽、咳白色泡沫状痰,晨起时咳嗽明显,咳嗽剧烈时伴左侧胸部隐痛,偶伴乏力、盗汗,无发热,无胸闷、气短,无心慌、心悸等不适。未予特殊重视,在当地诊所诊治,给予止咳、抗感

ACIEE:针对非小细胞肺癌EGFRT790M突变体的靶向化合物被设计

7月5日,记者在中科院广州生物医药与健康研究院获悉,该院科学家在克服非小细胞肺癌耐药研究方面获得新突破。相关结果在美国《药物化学杂志》和德国《应用化学》上在线发表。 肺癌是严重威胁人类健康的重大疾病,非小细胞肺癌则占所有类型肺癌的85%以上。目前,表皮生长因子(EGFR)受体抑制剂易瑞沙(吉非替尼)和特罗凯(埃罗替尼)等已在临床治疗非小细胞肺癌中获得巨大成功,但其耐药问题也日益突出。第二

Lancet Oncol:空气污染会增高肺癌发病风险

近期,在《柳叶刀肿瘤学》上发表的一项研究的结果指出,即使空气污染的程度低于欧盟所规定的标准,长期暴露在这些特定的空气污染中仍然会增加肺癌(尤其是肺腺癌)的发生风险。 来自日本冈山大学环境和生命科学研究生院的Takashi Yorifuji 和广岛大学的Saori Kashima在述评中指出:“在现阶段,我们需要将空气污染(甚至是现阶段的浓度)列为肺癌的致病因素,并且我们也需要认识到空气污